Changes of soluble CD40 ligand in the progression of acute myocardial infarction associate to endothelial nitric oxide synthase polymorphisms and vascular endothelial growth factor but not to platelet CD62P expression.
admin-cespu
Bibliographic reference:
Napoleão P., Monteiro M.C., Pina Cabral L., Criado B., Ramos C., Selas M., Viegas-Crespo A.M., Saldanha C., Mota-Carmo M., Cruz-Ferreira R., & Pinheiro T. (2015). Changes of soluble CD40 ligand in the progression of acute myocardial infarction associate to endothelial nitric oxide synthase polymorphisms and vascular endothelial growth factor but not to platelet CD62P expression. Translational Research,166:650–659.
Napoleão P., Monteiro M.C., Pina Cabral L., Criado B., Ramos C., Selas M., Viegas-Crespo A.M., Saldanha C., Mota-Carmo M., Cruz-Ferreira R., & Pinheiro T. (2015). Changes of soluble CD40 ligand in the progression of acute myocardial infarction associate to endothelial nitric oxide synthase polymorphisms and vascular endothelial growth factor but not to platelet CD62P expression. Translational Research,166:650–659.